Walmart settles US government's opioid lawsuit
Walmart Inc. agreed to pay $50 million to resolve a Justice Department lawsuit alleging its pharmacies unlawfully dispensed opioid prescriptions. This settlement concludes a federal enforcement action that lasted nearly six years. The retailer did not admit liability as part of the deal. To resolve the case, Walmart must follow the Controlled Substances Act and implement stricter safeguards to prevent prescription abuse. The final payment is significantly lower than the amount the Justice Department initially suggested the company might owe.
What changed
New reports indicate the $50 million settlement is considerably less than the amount the Justice Department initially suggested Walmart could owe.
Live updates
-
Walmart settles US government opioid lawsuit for $50 million
Walmart Inc. agreed to pay $50 million to resolve a Justice Department lawsuit alleging its pharmacies unlawfully dispensed opioid prescriptions. This settlement concludes a federal enforcement action that lasted nearly six years. The retailer did not admit liability as part of the deal. To resolve the case, Walmart must follow the Controlled Substances Act and implement stricter safeguards to prevent prescription abuse. The final payment is significantly lower than the amount the Justice Department initially suggested the company might owe.
Why it matters
The case focused on allegations that Walmart pharmacies filled thousands of invalid prescriptions, contributing to the nationwide opioid crisis. This settlement resolves one of the most significant government actions against a single company regarding opioid distribution.
What is confirmed
- Walmart agreed to pay $50 million to resolve a Justice Department lawsuit over opioid prescriptions.
- The retailer did not admit liability as part of the settlement.
- Walmart must adhere to the Controlled Substances Act and tighten safeguards to prevent prescription abuse.
- The federal enforcement case lasted nearly six years.
What to watch next
- Implementation and auditing of the new pharmacy safeguards
- Further DOJ actions against other retail pharmacies
confidence 100%Sources used for this update (4)
- journalrecord.com — On the Job: Healthcare tied to employment?
- journalrecord.com — Autism Foundation of Oklahoma to host free employment workshop
- www.kvom.com — Walmart and Major Retailers Face DOJ Antitrust Probe Over Rising Beef Prices
- finance.yahoo.com — Walmart Settles a Potential Multibillion-Dollar Opioid Case for $50 Million
-
Walmart settles DOJ opioid prescription lawsuit for $50 million
Walmart will pay $50 million to resolve a Justice Department lawsuit alleging its pharmacies knowingly filled thousands of invalid prescriptions for opioids and other controlled substances. The agreement concludes a federal enforcement case that lasted nearly six years. While the company must tighten safeguards to prevent further prescription abuse and adhere to the Controlled Substances Act, Walmart did not admit liability as part of the settlement.
Why it matters
The settlement addresses claims from the Department of Justice and the Drug Enforcement Administration. It focuses on the retailer's failure to maintain required pharmacy oversight. This case is part of a broader federal effort to curb the opioid crisis.
What is confirmed
- Walmart agreed to pay $50 million to settle a Justice Department lawsuit.
- The lawsuit accused Walmart pharmacies of filling thousands of invalid prescriptions for opioids and other controlled substances.
- Walmart did not admit liability in the settlement.
What to watch next
- Evidence of Walmart's implementation of the required pharmacy safeguards
- Further federal enforcement actions against other major pharmacy chains
confidence 100%Sources used for this update (5)
- www.lawcommentary.com — Walmart to Pay $50 Million to Settle DOJ Lawsuit Over Invalid Opioid Prescriptions
- www.marketscreener.com — Cardinal Infrastructure Unit Receives $40 Million Contract to Provide Civil Infrastructure Services for Walmart Facility in Georgia
- www.cheddar.com — Big Business This Week: Why Vegan Investing Has Beaten the Market
- journalrecord.com — SidexSide builds on 95% placement rate with third PFS loan
- journalrecord.com — Oklahoma State Regents approve first three-year bachelor’s degrees
-
Walmart settles federal opioid lawsuit for $50 million
Walmart will pay $50 million to resolve federal allegations that its pharmacies illegally filled thousands of invalid opioid prescriptions. As part of the settlement, the retailer must implement and tighten safeguards to prevent further prescription abuse. The agreement settles claims from the Department of Justice and Drug Enforcement Administration regarding the company's failure to adhere to the Controlled Substances Act.
Why it matters
The legal dispute began with a 2020 federal filing over the company's failure to report suspicious orders. Prosecutors alleged that while pharmacists flagged certain prescriptions, Walmart's compliance structure did not act on those warnings starting in June 2013.
What is confirmed
- Walmart will pay $50 million to settle federal allegations of illegally filling opioid prescriptions.
- The retailer must implement safeguards to prevent prescription abuse.
What to watch next
- Details on the specific compliance safeguards Walmart must implement
- Verification of the payment timeline to the US government
confidence 100%Sources used for this update (4)
- www.supermarketnews.com — Walmart settles federal opioid lawsuit for $50M
- www.knoe.com — Walmart to pay $50 million for illegally filling opioid prescriptions
- www.briefs.co — Gold Firms as US-Iran Strikes Stoke Inflation and Fed Hike Risks
- www.briefs.co — T. Rowe CEO Targets Tax-Loss Harvesting Growth, Says Offerings Should Avoid Scrutiny
-
Walmart pays $50 million to settle federal opioid prescription lawsuit
Walmart agreed to pay $50 million to resolve a Department of Justice and Drug Enforcement Administration lawsuit alleging the company filled thousands of prescriptions for opioids and other controlled substances without legitimate medical purposes. The federal government claimed Walmart violated the Controlled Substances Act starting in June 2013. While Walmart pharmacists flagged suspicious orders and filed refusal-to-fill forms, prosecutors argued the company's compliance structure failed to act on those warnings. The settlement ends a legal battle that began with a 2020 federal filing regarding the failure to report suspicious orders.
Why it matters
The case centers on the role of retail pharmacies in the broader opioid crisis. It highlights the tension between store-level pharmacist warnings and corporate compliance oversight. The resolution includes a new DEA framework for reporting and monitoring.
What is confirmed
- Walmart will pay $50 million to settle allegations from the Department of Justice and the Drug Enforcement Administration.
- The settlement addresses alleged violations of the Controlled Substances Act dating from June 2013.
- The lawsuit was filed in 2020.
- Federal prosecutors alleged Walmart's compliance structure failed to respond to thousands of refusal-to-fill forms submitted by its own pharmacists.
What to watch next
- Implementation of the new DEA compliance framework
- Potential similar settlements from other major retail pharmacy chains
confidence 100%Sources used for this update (7)
- www.briefs.co — Italian Energy Firm Expands Venezuela Operations Amid US Push
- www.briefs.co — France Faces Budget Crisis as Political Gridlock Threatens Stability
- www.briefs.co — Russia Extends Diesel Export Ban as Ukrainian Refinery Strikes Continue
- www.ibtimes.co.uk — Walmart Agrees To Pay $50M in DOJ Settlement Over Alleged Opioid Prescriptions at Its Pharmacies
- www.financial-world.org — Walmart agrees to $50 million opioid prescription settlement
- www.aol.com — Walmart settles DOJ opioid crisis lawsuit for $50 million
- finance.yahoo.com — Walmart to pay $50m to settle DOJ opioid-dispensing allegations
-
Walmart settles US government's opioid lawsuit for $50 million
Walmart has agreed to pay $50 million to settle a US government lawsuit alleging its pharmacies filled thousands of invalid prescriptions for opioids and other controlled substances since 2013. The settlement includes a new DEA compliance framework with specific reporting and monitoring requirements. This resolves allegations from the Justice Department and DEA.
Why it matters
The lawsuit, filed in 2020, accused Walmart of fueling the nationwide opioid epidemic by unlawfully dispensing prescriptions from its pharmacies. The settlement removes a significant legal overhang for the company. Walmart is the nation's largest retailer.
What is confirmed
- Walmart will pay $50 million to settle the US government's opioid lawsuit.
- The lawsuit alleged Walmart's pharmacies filled thousands of invalid prescriptions for opioids and other controlled substances since 2013.
- The settlement includes a new DEA compliance framework with specific reporting and monitoring requirements.
- The lawsuit was filed by the Justice Department and DEA in 2020.
What to watch next
- Walmart's implementation of the new DEA compliance framework
- Potential impact on Walmart's operations and reputation
- Any future lawsuits or actions related to opioid dispensing by Walmart
confidence 100%Sources used for this update (5)
- www.businesstimes.com.sg — Walmart settles US government’s opioid lawsuit, which sought billions, for US$50 million
- www.yahoo.com — Walmart settles DOJ opioid crisis lawsuit for $50 million
- www.fox10phoenix.com — Walmart agrees to pay $50M settlement over allegations its pharmacies filled illegal opioid prescriptions
- www.texarkanagazette.com — Walmart settles U.S. government's opioid lawsuit, which sought billions, for $50 million
- www.devdiscourse.com — Reuters US Domestic News Summary
-
Walmart settles federal lawsuit over opioid prescriptions
Walmart has agreed to settle a U.S. government lawsuit regarding the unlawful dispensing of opioids and other controlled substances. The company will pay $50 million to resolve allegations from the Justice Department and DEA that its pharmacies filled thousands of invalid prescriptions since 2013. As part of the agreement, Walmart must adhere to a new DEA compliance framework that mandates specific reporting and monitoring requirements. The settlement removes a legal overhang that had affected the company since the Justice Department first filed the suit in 2020.
Why it matters
The Justice Department alleged that Walmart's pharmacy practices fueled the opioid epidemic by failing to properly monitor prescriptions. This federal action followed years of scrutiny over how major retail pharmacies handled controlled substances. The case specifically targeted practices dating back to 2013.
What is confirmed
- Walmart settled a U.S. government lawsuit regarding the unlawful dispensing of opioids.
- The Justice Department sued Walmart in 2020.
- The lawsuit alleged that Walmart pharmacies unlawfully dispensed opioids and controlled substances since 2013.
- The settlement includes a new DEA compliance agreement with reporting and monitoring requirements.
Still unconfirmed
- Walmart is paying $50 million to resolve the DOJ and DEA allegations.
- Walmart shares rose following the settlement.
What to watch next
- Details of the specific DEA reporting and monitoring requirements
- Potential further legal actions from state governments regarding opioid dispensing
confidence 90%Sources used for this update (10)
- Financial Times — Walmart settles lawsuit over painkiller prescriptions
- CNBC — Walmart settles U.S. government's opioid lawsuit
- CBS News — Walmart settles Justice Department lawsuit over unlawfully dispensing opioids
- qz.com — Walmart settles federal opioid lawsuit over pharmacy practices
- Yahoo Finance — Walmart settles US government's opioid lawsuit
- www.yahoo.com — Walmart settles federal opioid lawsuit over pharmacy practices
- journalrecord.com — Walmart settles federal lawsuit over role in opioid epidemic
- www.arise.tv — Walmart Settles US Government Lawsuit Over Alleged Opioid Violations
- dailyhodl.com — Walmart Is Paying $50,000,000 To Settle DOJ Claims Over Opioid Prescriptions Lawsuit
- finance.yahoo.com — Walmart Shares Rise After $Billion-Scale Opioid Lawsuit Settlement